你好!欢迎访问
登录
|
立即注册
中文
|
0576-88813233
购物车
(0)
|
我的订单
首页
关于885566威尼斯
885566威尼斯产品
定制中心
客户服务
如何订购
新闻中心
积分换礼
联系我们
关于885566威尼斯
产品中心
客户定制
积分换礼
885566威尼斯产品
- 客户定制产品
- 前列腺素系列
- PI3K Inhibitors
- C-Kit Inhibitors
- VEGFR Inhibitors
- mTOR Inhibitors
- c-Met Inhibitors
- DNA/RNA Inhibitors
- HER2 Inhibitors
- Raf Inhibitors
- JAK Inhibitors
- Others
- SRC Inhibitors
- AKT Inhibitors
- CDK Inhibitors
浙江省台州市椒江开发大道东段288号万达广场2号楼
0576-88813233
0576-88670057
sales@dxymsy.com
合作客户
/
Partner
当前位置:885566威尼斯产品
ND-630
规格
价格
库存
数量
大包装询价
加入购物车
如您需要更多数量的报价,请点击立即获取报价或者通过电子邮件
sales@dxymsy.com
把您需要的数量信息提交给我们我们会在第一时间回复您,谢谢!
产品信息
产品名称:ND-630
纯度:98%min
CAS NO:1434635-54-7
溶解度:Soluble in DMSO
分子式:C
2
8
H
3
1
N
3
O
8
S
包装:可按客户要求包装。
分子量:569.63
贮存:Store at -20℃ 3 years
质量控制
备注说明
ND-630 is an acetyl-CoA carboxylase (
ACC
) inhibitor; inhibits human ACC1 and ACC2 with
IC
50
values of 2.1 and 6.1 nM, respectively.
ND-630 inhibits hACC1 (IC
50
=2.1±0.2 nM) and hACC2 (IC
50
=6.1±0.8 nM). Inhibition is reversible and highly specific for ACC. ND-630 inhibits ACC activity by interacting within the phosphopeptide-acceptor and dimerization site of the enzyme to prevent dimerization. ND-630 inhibits fatty acid synthesis with an EC
50
of 66 nM in HepG2 cells without altering the total cell number, cellular protein concentration, and incorporation of acetate into cholesterol
[1]
.
Chronical administration of ND-630 to rats with diet-induced obesity reduces hepatic steatosis, improves insulin sensitivity, reduces weight gain without affecting food intake, and favorably affects dyslipidemia. Chronical administration of ND-630 Zucker diabetic fatty rats, ND-630 reduces hepatic steatosis, improves glucose-stimulated insulin secretion, and reduces hemoglobin A1c (0.9% reduction). ND-630 exhibits an aqueous solubility of 594 μM and human and rat plasma protein binding of 98.5% and 98.6%, respectively. Pharmacokinetic evalsuation of ND-630 in male Sprague–Dawley rats [i.v. 3 mg/kg; orally (p.o.) 10 mg/kg] yields a plasma t
1/2
of 4.5 h, bioavailability of 37%, clearance of 33 mL/min/kg, volume of distribution of 1.9 L/kg, oral time of maximum plasma concentration of 0.25 h
[1]
.
参考文献
[1].
首页
|
关于885566威尼斯
|
885566威尼斯产品
|
定制中心
|
客户服务
|
如何订购
|
新闻中心
|
积分换礼
|
联系我们
版权所有 Copyright(C) 2018-2024 台州市885566威尼斯生物技术有限公司
技术支持:
kerui
浙ICP备09021343号
-1
公司所列产品中涉及到专利,只供研发使用,不做销售;管制产品将严格遵守中国法律和购买客户国法律的规定销售,所有产品都不适用于人用 如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。
网站地图